Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

Last edition

News about "central nervous system "

JCR Pharmaceuticals and Modalis to Develop Novel Gene Therapy

The purpose of this joint agreement is to conduct pre-clinical studies for the development of a new gene therapy for the undisclosed CNS disease by applying J-Brain Cargo®, JCR’s proprietary technology.

Central Nervous System | 06/01/2025 | By Aishwarya

AbbVie Announces Acquisition of Aliada Therapeutics

Aliada's lead investigational asset is ALIA-1758, an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody, which is in development for the treatment of patients with Alzheimer's disease and is currently in a Phase 1 clinical trial.

Central Nervous System | 13/12/2024 | By Aishwarya

AbbVie and Gedeon Richter to Develop Novel Targets for Neuropsychiatric Conditions

This collaboration expands upon the success of nearly two decades of partnership on central nervous system (CNS) projects, including globally launched products such as cariprazine (VRAYLAR / REAGILA) and the discovery of investigational drug candidate ABBV-932 for the treatment of bipolar depression and generalized anxiety disorder.

Central Nervous System | 25/10/2024 | By Aishwarya

Lupin Rolls Out First Generic Version of Oracea

Lupin has unveiled the first generic version of Oracea (Doxycycline Capsules, 40 mg), in the United States.

Central Nervous System | 10/04/2024 | By Aishwarya | 262

First Use of Kyverna KYV-101 in Patients with Progressive Multiple Sclerosis Published

Kyverna Therapeutics, Inc. has announced about a recent report published in Med that describes the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in two patients suffering from progressive multiple sclerosis (MS).

Central Nervous System | 30/03/2024 | By Manvi | 463